Contact
Please use this form to send email to PR contact of this press release:
FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)
TO:
Please use this form to send email to PR contact of this press release:
FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)
TO: